Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of Different Doses of Indacaterol

ClinicalTrials.gov ID: NCT01079130

Public ClinicalTrials.gov record NCT01079130. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 6:08 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Double-dummy, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Different Doses of Indacaterol in Adult Patients With Persistent Asthma, Using Salmeterol as an Active Control

Study identification

NCT ID
NCT01079130
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
511 participants

Conditions and interventions

Conditions

Interventions

  • Indacaterol Drug
  • Placebo to Indacaterol Drug
  • Placebo to Salmeterol Drug
  • Salmeterol Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2010
Primary completion
Jun 30, 2010
Completion
Not listed
Last update posted
Aug 18, 2011

Started 2010

United States locations

U.S. sites
71
U.S. states
26
U.S. cities
67
Facility City State ZIP Site status
Novartis Investigator Site Glendale Arizona 85306
Novartis Investigator Site Scottsdale Arizona 85251
Novartis Investigator Site Encinitas California 92024
Novartis Investigator Site Huntington Beach California 92647
Novartis Investigator Site Los Angeles California 90025
Novartis Investigator Site Los Angeles California 90048
Novartis Investigative Site Mission Viejo California 92691
Novartis Investigator Site Orange California 92868
Novartis Investigator Site Rancho Mirage California 92270
Novartis Investigator Site Rolling Hills Estates California 90274
Novartis Investigator Site San Diego California 92120
Novartis Investigator Site San Diego California 92123
Novartis Investigator Site San Jose California 95117
Novartis Investigator Site Stockton California 95207
Novartis Investigator Site Colorado Springs Colorado 80907
Novartis Investigator Site Denver Colorado 80230
Novartis Investigator Site Engelwood Colorado 80112
Novartis Investigator Site Lakewood Colorado 80401
Novartis Investigative Site Stamford Connecticut 06902
Novartis Investigative Site Waterbury Connecticut 06708
Novartis Investigative site Destin Florida 32541
Novartis Investigative Site Pensacola Florida 32503
Novartis Investigative Site Pensacola Florida 32514
Novartis Investigative Site Port Orange Florida 32127
Novartis Investigative Site Sarasota Florida 34233
Novartis Investigative Site Tamarac Florida 33321
Novartis Investigative Site Winter Park Florida 32789
Novartis Investigator Site Boise Idaho 83704
Novartis Investigator Site Normal Illinois 61761
Novartis Investigative Site Springfield Illinois 62703
Novartis Investigator Site Overland Park Kansas 66210
Novartis Investigative Site Louisville Kentucky 40215
Novartis Investigator Site Lafayette Louisiana 70503
Novartis Investigative Site Baltimore Maryland 21236
Novartis Investigator Site Columbia Maryland 21044
Novartis Investigative Site Wheaton Maryland 20902
Novartis Investigative Site North Dartmouth Massachusetts 02747
Novartis Investigative Site Minneapolis Minnesota 55402
Novartis Investigator Site Columbia Missouri 65203
Novartis Investigator Site Rolla Missouri 65401
Novartis Investigator Site St Louis Missouri 63141
Novartis Investigator Site Warrensburg Missouri 64093
Novartis Investigative Site Missoula Montana 59808
Novartis Investigator Site Bellevue Nebraska 68123
Novartis Investigator Site Boys Town Nebraska 68010
Novartis Investigative Site Ocean City New Jersey 07712
Novartis Investigative Site Skillman New Jersey 08558
Novartis Investigative Site Charlotte North Carolina 28207
Novartis Investigative Site Raleigh North Carolina 27607
Novartis Investigator Site Cadiz Ohio 43907
Novartis Investigative Site Columbus Ohio 43215
Novartis Investigative Site Maumee Ohio 43537
Novartis Investigator Site Oklahoma City Oklahoma 73103
Novartis Investigator Site Lake Oswego Oregon 97035
Novartis Investigative Site Medford Oregon 97504
Novartis Investigator Site Portland Oregon 97213
Novartis Investigative Site Erie Pennsylvania 16506
Novartis Investigative Site Phoenixville Pennsylvania 19460
Novartis Investigative Site Pittsburgh Pennsylvania 15243
Novartis Investigative Site Upland Pennsylvania 19013
Novartis Investigative Site Lincoln Rhode Island 02865
Novartis Investigative Site Charleston South Carolina 29414
Novartis Investigative site North Charleston South Carolina 29406
Novartis Investigator Site Austin Texas 78758
Novartis Investigator Site Dallas Texas 75231
Novartis Investigator Site El Paso Texas 79903
Novartis Investigator Site El Paso Texas 79925
Novartis Investigator Site Georgetown Texas 78628
Novartis Investigator Site North Richland Hills Texas 76180
Novartis Investigator Site Waco Texas 73712
Novartis Investigator Site Seattle Washington 98105

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01079130, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 18, 2011 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01079130 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →